12 Jun 2019

VICI VENOUS STENT: FDA OKs VICI Venous Stent to treat Iliofemoral obstructive disease

    The U.S Food and Drug Administration has approved Boston Scientific’s VICI Venous Stent System for the treatment of iliofemoral venous obstructive disease, which occurs when the flow of blood through the veins located deep in the pelvic region becomes blocked by a blood clot or compressed by anatomical anomalies.

0
12 Jun 2019

VECLOSE EXTENSION STUDY: Five-year outcomes prove durability, safety, efficacy of VenaSeal Closure System

    By Larry Storer Five-year results from the 2019 VeClose Extension Study of the Medtronic VenaSeal Closure System demonstrate that the treatment modality is consistent, durable and safe for permanently closing veins in patients with venous reflux disease. When compared with Medtronic Radiofrequency Ablation, VenaSeal continued to show “non-inferiority”

0
12 Jun 2019

MERZ REGAINS SOLE DISTRIBUTION OF ASCLERA FROM ANGIODYNAMICS

  Merz North America Inc. has regained exclusive distribution of Asclera (polidocanol) Injection in the United States to all healthcare practitioners and phlebologists treating varicose veins. Also effective April 8, AngioDynamics Inc. is no longer an authorized distributor of Asclera. All HCPs will now be able to purchase Asclera directly

0
12 Jun 2019

NEVER SAY DIE: WHY MOST DOCTORS WON’T BREAK BAD NEWS

  By JoNel Aleccia After nearly 40 years as an internist, Portland, Oregon physician Ron Naito knew what the sky-high results of his blood test meant. And it wasn’t good. But when he turned to his doctors last summer to confirm the dire diagnosis — stage 4 pancreatic cancer —

0
11 Jun 2019

WHEN IT COMES TO OUR HEALTH – EVERY SECOND COUNTS

By Seema Verma Healthcare: American’s favorite debate topic.  While there is much to debate, we can all agree that the patient-provider relationship has been strained by unnecessary regulations and reporting requirements. Too much regulation has had the unintentional result of putting the government first and the patient second.  Time spent

0
11 Jun 2019

VIVA PHYSICIANS TO PARTICIPATE IN FDA HEARING ON DRUG-ELUTING AND DRUG-COATED DEVICES

On June 19-20, VIVA physicians will participate in a Food and Drug Administration Open Public Hearing to addresses the possible correlation between drug-eluting and -coated devices and late mortality at the Gaithersburg Holiday Inn Grand Ballroom in Gaithersburg, Maryland. VIVA has spearheaded a pan-industry effort to analyze patient level data

0
10 Jun 2019

AVLS offers sclerotherapy and hands-on ultrasound courses Aug. 10

            Margaret Mann, MD, FACPh, will conduct the American Vein and Lymphatic Society Sclerotherapy Course Aug. 10 in Arlington, Va.             The Sclerotherapy Course is a comprehensive one-day lecture series, reviewing both the theoretical and practical essentials of sclerotherapy. This course will enhance your sclerotherapy knowledge

0
07 Jun 2019

SOCIAL SECURITY ERROR JEOPARDIZES MEDICARE COVERAGE FOR 250,000 SENIORS

By Susan Jaffe   At least a quarter of a million Medicare beneficiaries may receive bills for as many as five months of premiums they thought they already paid. But they shouldn’t toss the letter in the garbage. It’s not a scam or a mistake.   Because of what the

0
07 Jun 2019

A LARGE EMPLOYER ‘FRAMES’ THE ‘MEDICARE FOR ALL’ DEBATE

  By Phil Galewitz   Walk into a big-box retailer such as Walmart or Michaels and you’re likely to see MCS Industries’ picture frames, decorative mirrors or kitschy wall décor. Adjacent to a dairy farm a few miles west of downtown Easton, MCS is the nation’s largest maker of such household

0
06 Jun 2019

NAVIGATING AGING: A DOCTOR SPEAKS OUT ABOUT AGEISM IN MEDICINE

NAVIGATING AGING: A DOCTOR SPEAKS OUT ABOUT AGEISM IN MEDICINE By Judith Graham Society gives short shrift to older age. This distinct phase of life doesn’t get the same attention that’s devoted to childhood. And the special characteristics of people in their 60s, 70s, 80s and beyond are poorly under Medicine

0